Collagen and HA-based Biomaterials Market

Collagen and HA-based Biomaterials Market Analysis By Type (Facial Aesthetics Dermal Fillers, Viscosupplements, Viscoelastics, Wound Dressings, Others), By Application (Food, Medicine, Cosmetics), & By Region - Global Market Insights 2022-2027

Analysis of Collagen and HA-based Biomaterials market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Collagen and HA-based Biomaterials Market Outlook (2022-2027)

The global collagen and HA-based biomaterials market is set to enjoy a valuation of US$ 8 billion in 2022 and further increase at a CAGR of 6% to reach US$ 10.8 billion by the year 2027.

Sales of facial aesthetics dermal fillers are predicted to increase faster at a CAGR of 6.5% and reach a market size of US$ 5.5 billion by 2027.

Report Attributes

Details

Collagen and HA-based Biomaterials Market Size (2022E)

US$ 8 Billion

Forecasted Market Value (2027F)

US$ 10.8 Billion

Global Market Growth Rate (2022-2027)

6% CAGR

China Market Growth Rate (2022-2027)

9% CAGR

Share in Biomaterials Market (2022)

20%

Key Companies Profiled

  • Alcon Laboratories Inc.
  • Allergan plc
  • Anika Therapeutics Inc.
  • Bausch & Lomb Inc.
  • Collagen Solutions Plc
  • Galderma S.A.
  • Lifecore Biomedical LLC
  • Sanofi US
  • Seikagaku Corporation
  • Teijin Pharma Limited

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Sales Analysis of Collagen and HA-based Biomaterials (2017-2021) Vs. Market Predictions (2022-2027)

One of the most common protein types in the human body is collagen, which has seen a significant increase in application in tissue engineering due to its accessibility, biodegradability, adaptability, and biocompatibility.

Exogenous hyaluronic and hyaluronan-based biomaterials have been successfully used in a variety of medical fields, including dermatology, rheumatology, and ophthalmology, as well as in wound healing and cosmetic procedures.

Biomaterials are one of the most significant materials utilised in pharmaceutical and healthcare industries. Due to their widespread availability and biocompatibility, collagen and HA-based biomaterials are frequently employed in bone tissue engineering. The development of prosthetics, the food industry, personal healthcare, and regenerative medicine all have potential uses for collagen and HA-based biomaterials. Collagen-based biomaterials for wound healing are an effective treatment method.

The global market for collagen and HA-based biomaterials is expected to experience healthy growth over the forecast period due to factors including an increase in cosmetic surgeries across the globe, technological developments, the introduction of advanced collagen-based products in industrialized regions, rise in the prevalence of joint disorders globally, and the knowledge of benefits that HA-based biomaterials provide.

Expanding at a CAGR of 6%, the global collagen and HA-based biomaterials market is projected to reach a valuation of US$ 10.8 billion by 2027, says Fact.MR, a market research and competitive intelligence provider, in its recent study on the global collagen and HA-based biomaterials market.

Collagen and HA-based biomaterials market growth forecast by Fact.MR

What is Enhancing the Collagen and HA-based Biomaterials Market Share?

“Huge Arthritis Patients Populace Moving towards Viscosupplementation”

During viscosupplementation, a gel-like material (hyaluronic acid) is pushed into the kneecap, which helps to reduce pain in joints. Companies that produce viscosupplementation devices are scrambling to create and obtain new drug approvals for the treatment of elbow, hip, and knee osteoarthritis.

Viscosupplementation for knee osteoarthritis is projected to be a key growth driver, followed by hip osteoarthritis. The major justification is that viscosupplementation can reduce the chances of knee surgery.

Anti-inflammatory medications now include viscosupplementation. Manufacturers are concentrating their efforts on creating and promoting innovative viscosupplementation solutions in response to the rising demand for viscosupplementation devices.

Furthermore, as the elderly are more prone to musculoskeletal disorders such as osteoarthritis, the expanding senior population worldwide with joint disorders would stimulate market expansion for collagen and HA-based biomaterials over the anticipated timeframe.

“Rapid Rise in Number of Cosmetic Surgeries”

The market has been growing over the last few years as millennials' enthusiasm for fitness increases. During the projection period, it is projected that both the technological development of cosmetic surgery devices and the increased demand for less invasive procedures would considerably promote market growth.

  • The American Society of Plastic Surgeons estimates that 13,281,235 cosmetic minimally-invasive surgeries were carried out in the country in 2020.

Furthermore, it is projected that the launch of new cosmetic products in the sector will significantly fuel the collagen and HA-based biomaterials market growth.

  • For instance, the RHA (resilient hyaluronic acid) collection of fillers was launched by Revance.

These elements, combined with rising public awareness and the trend of cosmetic surgery, are projected to propel the market for collagen and HA-based biomaterials over the coming years.

What Challenges are Faced by Companies in the Collagen and HA-based Biomaterials Market?

“Religious Beliefs Affecting Collagen and HA-based Biomaterials Business”

Religious and cultural views are progressively impeding the adoption and acceptance of collagen and hyaluronic acid-based biomaterials as animal-derived components, particularly in the case of collagen sources, becoming more and more a part of healthcare.

Pigs and cows are excellent sources of collagen, but the use of products manufactured from these sources is challenging in various regional markets due to religious beliefs, which has a detrimental effect on the expansion of the worldwide market for collagen and HA-based biomaterials.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Why is Asia Pacific Emerging as a Profitable Market for Collagen and HA-based Biomaterials?

“High Number of Chronic Arthritis Cases & Anti-ageing Cosmetic Surgeries in Asia Pacific”

Concerning the market for collagen and HA-based biomaterials, North America is in the lead, followed by Europe. Rising incidence of various skin diseases, creation of technologically sophisticated collagen-based biomaterials, use of single-injection viscosupplements, and the rising desire of people to maintain good health as they age are some of the main drivers of market expansion in these regions.

The Asia Pacific is among the most profitable market for the growth of collagen and HA-based biomaterials. High market penetration, rising collagen demand for bone tissue regeneration in developing regions, an increase in the number of elderly people suffering from chronic arthritis as a result of high population density in countries such as China and India, an increase in the need for people to choose anti-ageing treatments to improve their physical appearance, and rising spending power of the populace are the main factors driving the collagen and HA-based biomaterials market growth in Asia Pacific.

Country-wise Analysis

What is Supporting U.S. Collagen and HA-based Biomaterials Market Growth?

“Awareness Initiatives Regarding Collagen and HA-based Biomaterials by Government & Private Organizations”

Due to efforts made by numerous governmental and private organisations, the United States currently dominates the North American market and is anticipated to hold the highest revenue share in 2022.

These organisations comprise the National Science Foundation and the National Institute of Standards and Technology, which offer advice and information on the use of biomaterials in biological applications. The usage of biomaterials and collagen in biological applications in this nation has increased as a result of such initiatives.

The U.S. market share has also been influenced by other elements such as favourable government policies, high trend of cosmetic surgeries to look good, and the existence of several significant market participants in this nation.

What is the Outlook for Cosmetic Treatment in China?

“Advancement of Dermal Fillers Complementing China’s Collagen and HA-based Biomaterials Market Expansion”

The China market for collagen and HA-based biomaterials is anticipated to benefit over the coming years due to the rising demand for anti-ageing cosmetic operations. The ongoing advancements of dermal fillers present a lucrative business opportunity for China market.

Players in the nation are also making several efforts to improve their market positions.

  • For instance, China National Biotech Group Company Ltd. (CNBG) and Croma Pharma GmBH established a joint venture agreement in China in September 2020. The strategy is anticipated to increase the company's footprint in China and boost sales throughout the anticipated time frame.

Thus, the above factors are contributing to the sales of collagen and HA-based biomaterials in the country.

Category-wise Analysis

Why is Demand for Facial Aesthetics Dermal Fillers So High?

“Craze to Look Good Driving Popularity of Facial Cosmetic Surgeries”

The need for cosmetic procedures has grown significantly in the current world, particularly non-invasive cosmetic surgeries such as dermal fillers. To obtain a cosmetic result, these gel-like materials are also injected under the skin of the face. Dermal fillers are utilized for a variety of purposes, including the treatment of acne scars, wrinkles, and facial lines.

These treatments are anticipated to increase the number of cosmetic procedures performed as people's spending power on self-care is increasing around the world, particularly in emerging nations. Furthermore, the ultimate taboos linked with cosmetic procedures have been greatly diminished by the growing understanding of filler procedures. The adoption of these products is anticipated to be strongly influenced by such shifts in mindsets.

Several companies that manufacture facial injectable dermal fillers have made considerable research and development investments in response to these promising market growth trends. These R&D endeavours have produced a significant number of dermal filler products with significantly better aesthetic results.

During the projected period, these dermal filler product introductions are also anticipated to have a significant positive impact on collagen and HA-biomaterial market expansion. Therefore, increased demand for facial cosmetic procedures as well as the launch of new products with a variety of applications will significantly fuel the demand for facial aesthetics dermal fillers over the forecast period.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Competitive Landscape

Major firms in the collagen and HA-based biomaterials market are focusing on creating advanced biomaterials. They are also employing growth strategies such as mergers and acquisitions, new product launches, partnerships, and more.

The competitive landscape section includes key global growth strategies, market dominance, and market ranking analysis of major companies such as Galderma Laboratories L.P., Bausch Health Companies Inc., Anika Therapeutics, Inc., Collagen Solutions Plc, Abbott Laboratories, Johnson & Johnson Services, Inc., Allergan plc, Sanofi, and BioCell Technology LLC.

  • A global unique developmental and commercialization contract for dermal and soft tissue filler solutions was signed by CollPlant Biotechnologies (NASDAQ: CLGN) and Allergan Aesthetics, an AbbVie company, in February 2021.
  • In February 2020, Anika Therapeutics, Inc., a leading privately held provider of joint surface and preservation solutions for active patients, announced the acquisition of Arthrosurface. Anika Therapeutics, Inc. is a global, integrated joint regenerative and preservation therapies manufacturer.
  • Allergan Aesthetics, an AbbVie corporation, announced the release of the SkinMedica® Neck Correct Cream in April 2021. This is the first item in the line's skilful skincare collection designed to treat the unique anatomy of the skin on the neck and decolletage. The SkinMedica® Neck Correct Cream was created for both, curing and preventing the initial signs of mild to serious neck degeneration.

Collagen and HA-based Biomaterials Industry Research Segments

  • By Type :

    • Facial Aesthetics Dermal Fillers
    • Viscosupplements
    • Viscoelastics
    • Wound Dressings
    • Others
  • By Application :

    • Food
    • Medicine
    • Cosmetics
  • By Region :

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • MEA

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions/Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Type modifications /Innovation

4. Key Success Factors

    4.1. Strategic Developments

    4.2. Key regulations

    4.3. Type USPs /Technology

    4.4. List of Manufacturers and Providers

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP outlook

        5.1.2. Increasing R&D Expenditure

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. New Type launches

        5.2.2. Cost of Types

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as Compared to 2008 Economic analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Type

        6.4.2. Revenue By Application

        6.4.3. Revenue By Country

    6.5. 2021 Market Scenario

    6.6. Quarter by Quarter Forecast

    6.7. Projected Recovery Quarter

7. Global Collagen and HA-based Biomaterials Market Volume (Units) Analysis 2017-2021 and Forecast, 2022-2027

    7.1. Historical Market Volume (Units) Analysis, 2017-2021

    7.2. Current and Future Market Volume (Units) Projections, 2022-2027

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Collagen and HA-based Biomaterials Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Type

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

9. Global Collagen and HA-based Biomaterials Market Value Analysis 2017–2021 and Forecast, 2022-2027

    9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2027

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Collagen and HA-based Biomaterials Market Analysis 2017–2021 and Forecast 2022-2027, by Type

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Types & Services, 2017–2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022-2027

        10.3.1. Facial Aesthetics Dermal Fillers

        10.3.2. Viscosupplements

        10.3.3. Viscoelastics

        10.3.4. Wound Dressings

        10.3.5. Others

    10.4. Market Attractiveness Analysis By Type

11. Global Collagen and HA-based Biomaterials Market Analysis 2017–2021 and Forecast 2022-2027, by Application

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Application , 2017–2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application , 2022-2027

        11.3.1. Food

        11.3.2. Medicine

        11.3.3. Cosmetics

    11.4. Market Attractiveness Analysis By Application

12. Global Collagen and HA-based Biomaterials Market Analysis 2017–2021 and Forecast 2022-2027, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021

    12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2027

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Collagen and HA-based Biomaterials Market Analysis 2017–2021 and Forecast 2022-2027

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        13.3.1. By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Type

        13.3.3. By Application

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Latin America Collagen and HA-based Biomaterials Market Analysis 2017–2021 and Forecast 2022-2027

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        14.3.1. By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Type

        14.3.3. By Application

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Europe Collagen and HA-based Biomaterials Market Analysis 2017–2021 and Forecast 2022-2027

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. Russia

            15.3.1.7. Rest of Europe

        15.3.2. By Type

        15.3.3. By Application

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. South Asia Collagen and HA-based Biomaterials Market Analysis 2017–2021 and Forecast 2022-2027

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Type

        16.3.3. By Application

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. East Asia Collagen and HA-based Biomaterials Market Analysis 2017–2021 and Forecast 2022-2027

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        17.3.1. By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

            17.3.1.4. Rest of East Asia

        17.3.2. By Type

        17.3.3. By Application

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Oceania Collagen and HA-based Biomaterials Market Analysis 2017–2021 and Forecast 2022-2027

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Type

        18.3.3. By Application

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Collagen and HA-based Biomaterials Market Analysis 2017–2021 and Forecast 2022-2027

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. South Africa

            19.3.1.3. Rest of Middle East and Africa

        19.3.2. By Type

        19.3.3. By Application

    19.4. Market Attractiveness Analysis

    19.5. Drivers and Restraints - Impact Analysis

20. Key and Emerging Countries Collagen and HA-based Biomaterials Market Analysis 2017–2021 and Forecast 2022-2027

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. U.S. Collagen and HA-based Biomaterials Market Analysis

        20.2.1. By Type

        20.2.2. By Application

    20.3. Canada Collagen and HA-based Biomaterials Market Analysis

        20.3.1. By Type

        20.3.2. By Application

    20.4. Mexico Collagen and HA-based Biomaterials Market Analysis

        20.4.1. By Type

        20.4.2. By Application

    20.5. Brazil Collagen and HA-based Biomaterials Market Analysis

        20.5.1. By Type

        20.5.2. By Application

    20.6. U.K. Collagen and HA-based Biomaterials Market Analysis

        20.6.1. By Type

        20.6.2. By Application

    20.7. Germany Collagen and HA-based Biomaterials Market Analysis

        20.7.1. By Type

        20.7.2. By Application

    20.8. France Collagen and HA-based Biomaterials Market Analysis

        20.8.1. By Type

        20.8.2. By Application

    20.9. Italy Collagen and HA-based Biomaterials Market Analysis

        20.9.1. By Type

        20.9.2. By Application

    20.10. Spain Collagen and HA-based Biomaterials Market Analysis

        20.10.1. By Type

        20.10.2. By Application

    20.11. BENELUX Collagen and HA-based Biomaterials Market Analysis

        20.11.1. By Type

        20.11.2. By Application

    20.12. Russia Collagen and HA-based Biomaterials Market Analysis

        20.12.1. By Type

        20.12.2. By Application

    20.13. China Collagen and HA-based Biomaterials Market Analysis

        20.13.1. By Type

        20.13.2. By Application

    20.14. Japan Collagen and HA-based Biomaterials Market Analysis

        20.14.1. By Type

        20.14.2. By Application

    20.15. South Korea Collagen and HA-based Biomaterials Market Analysis

        20.15.1. By Type

        20.15.2. By Application

    20.16. India Collagen and HA-based Biomaterials Market Analysis

        20.16.1. By Type

        20.16.2. By Application

    20.17. ASEAN Collagen and HA-based Biomaterials Market Analysis

        20.17.1. By Type

        20.17.2. By Application

    20.18. Australia Collagen and HA-based Biomaterials Market Analysis

        20.18.1. By Type

        20.18.2. By Application

    20.19. New Zealand Collagen and HA-based Biomaterials Market Analysis

        20.19.1. By Type

        20.19.2. By Application

    20.20. GCC Countries Collagen and HA-based Biomaterials Market Analysis

        20.20.1. By Type

        20.20.2. By Application

    20.21. Turkey Collagen and HA-based Biomaterials Market Analysis

        20.21.1. By Type

        20.21.2. By Application

    20.22. South Africa Collagen and HA-based Biomaterials Market Analysis

        20.22.1. By Type

        20.22.2. By Application

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

    21.4. Market Presence Analysis

        21.4.1. By Regional footprint of Players

        21.4.2. Type foot print by Players

        21.4.3. Channel Foot Print by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep dive

        22.3.1. Alcon Laboratories Inc.

            22.3.1.1. Overview

            22.3.1.2. Type Portfolio

            22.3.1.3. Profitability by Market Segments (Type/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

        22.3.2. Allergan plc

            22.3.2.1. Overview

            22.3.2.2. Type Portfolio

            22.3.2.3. Profitability by Market Segments (Type/Channel/Region)

            22.3.2.4. Sales Footprint

            22.3.2.5. Strategy Overview

        22.3.3. Anika Therapeutics Inc.

            22.3.3.1. Overview

            22.3.3.2. Type Portfolio

            22.3.3.3. Profitability by Market Segments (Type/Channel/Region)

            22.3.3.4. Sales Footprint

            22.3.3.5. Strategy Overview

        22.3.4. Bausch & Lomb Inc.

            22.3.4.1. Overview

            22.3.4.2. Type Portfolio

            22.3.4.3. Profitability by Market Segments (Type/Channel/Region)

            22.3.4.4. Sales Footprint

            22.3.4.5. Strategy Overview

        22.3.5. Collagen Solutions Plc

            22.3.5.1. Overview

            22.3.5.2. Type Portfolio

            22.3.5.3. Profitability by Market Segments (Type/Channel/Region)

            22.3.5.4. Sales Footprint

            22.3.5.5. Strategy Overview

        22.3.6. Galderma S.A.

            22.3.6.1. Overview

            22.3.6.2. Type Portfolio

            22.3.6.3. Profitability by Market Segments (Type/Channel/Region)

            22.3.6.4. Sales Footprint

            22.3.6.5. Strategy Overview

        22.3.7. Lifecore Biomedical LLC

            22.3.7.1. Overview

            22.3.7.2. Type Portfolio

            22.3.7.3. Profitability by Market Segments (Type/Channel/Region)

            22.3.7.4. Sales Footprint

            22.3.7.5. Strategy Overview

        22.3.8. Sanofi US

            22.3.8.1. Overview

            22.3.8.2. Type Portfolio

            22.3.8.3. Profitability by Market Segments (Type/Channel/Region)

            22.3.8.4. Sales Footprint

            22.3.8.5. Strategy Overview

        22.3.9. Seikagaku Corporation

            22.3.9.1. Overview

            22.3.9.2. Type Portfolio

            22.3.9.3. Profitability by Market Segments (Type/Channel/Region)

            22.3.9.4. Sales Footprint

            22.3.9.5. Strategy Overview

        22.3.10. Teijin Pharma Limited

            22.3.10.1. Overview

            22.3.10.2. Type Portfolio

            22.3.10.3. Profitability by Market Segments (Type/Channel/Region)

            22.3.10.4. Sales Footprint

            22.3.10.5. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Collagen and HA-based Biomaterials Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017–2027, By Type

Table 02: Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type

Table 03: Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application

Table 04: Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Region

Table 05: North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 06: North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type

Table 07: North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application

Table 08: Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 09: Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type

Table 10: Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application

Table 11: Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 12: Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type

Table 13: Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application

Table 14: South Asia Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 15: South Asia Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type

Table 16: South Asia Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application

Table 17: East Asia Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 18: East Asia Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type

Table 19: East Asia Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application

Table 20: Oceania Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 21: Oceania Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type

Table 22: Oceania Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application

Table 23: Middle East and Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country

Table 24: Middle East and Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Type

Table 25: Middle East and Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Application

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Collagen and HA-based Biomaterials Market Volume (in 000' Units) Analysis, 2017-2021

Figure 02: Global Collagen and HA-based Biomaterials Market Volume Forecast (in 000' Units), 2022-2027

Figure 03: Collagen and HA-based Biomaterials Pricing Analysis (US$) Per Type, By Region, 2021

Figure 04: Collagen and HA-based Biomaterials Pricing Analysis (US$) Per Type, By Region, 2021

Figure 05: Global Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2017-2021

Figure 06: Global Collagen and HA-based Biomaterials Market Value Forecast (US$ Mn), 2022-2027

Figure 07: Global Collagen and HA-based Biomaterials Market Absolute $ Opportunity, 2022-2027

Figure 08: Global Collagen and HA-based Biomaterials Market Share Analysis (%), By Type, 2022-2027

Figure 09: Global Collagen and HA-based Biomaterials Market Y-o-Y Analysis (%), By Type, 2022-2027

Figure 10: Global Collagen and HA-based Biomaterials Market Attractiveness Analysis by Type, 2022-2027

Figure 11: Global Collagen and HA-based Biomaterials Market Share Analysis (%), By Application, 2022-2027

Figure 12: Global Collagen and HA-based Biomaterials Market Y-o-Y Analysis (%), By Application, 2022-2027

Figure 13: Global Collagen and HA-based Biomaterials Market Attractiveness Analysis by Application, 2022-2027

Figure 14: Global Collagen and HA-based Biomaterials Market Share Analysis (%), By Region, 2022-2027

Figure 15: Global Collagen and HA-based Biomaterials Market Y-o-Y Analysis (%), By Region, 2022-2027

Figure 16: Global Collagen and HA-based Biomaterials Market Attractiveness Analysis by Region, 2022-2027

Figure 17: North America Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 18: North America Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 19: North America Collagen and HA-based Biomaterials Market Value Share, By Country, 2022 (E)

Figure 20: North America Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2017-2021

Figure 21: North America Collagen and HA-based Biomaterials Market Value Forecast (US$ Mn), 2022-2027

Figure 22: North America Collagen and HA-based Biomaterials Market Attractiveness Analysis by Type, 2022-2027

Figure 23: North America Collagen and HA-based Biomaterials Market Attractiveness Analysis by Application, 2022-2027

Figure 24: North America Collagen and HA-based Biomaterials Market Attractiveness Analysis by Country, 2022-2027

Figure 25: Latin America Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 26: Latin America Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 27: Latin America Collagen and HA-based Biomaterials Market Value Share, By Country, 2022 (E)

Figure 28: Latin America Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2017-2021

Figure 29: Latin America Collagen and HA-based Biomaterials Market Value Forecast (US$ Mn), 2022-2027

Figure 30: Latin America Collagen and HA-based Biomaterials Market Attractiveness Analysis by Type, 2022-2027

Figure 31: Latin America Collagen and HA-based Biomaterials Market Attractiveness Analysis by Application, 2022-2027

Figure 32: Latin America Collagen and HA-based Biomaterials Market Attractiveness Analysis by Country, 2022-2027

Figure 33: Europe Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 34: Europe Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 35: Europe Collagen and HA-based Biomaterials Market Value Share, By Country, 2022 (E)

Figure 36: Europe Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2017-2021

Figure 37: Europe Collagen and HA-based Biomaterials Market Value Forecast (US$ Mn), 2022-2027

Figure 38: Europe Collagen and HA-based Biomaterials Market Attractiveness Analysis by Type, 2022-2027

Figure 39: Europe Collagen and HA-based Biomaterials Market Attractiveness Analysis by Application, 2022-2027

Figure 40: Europe Collagen and HA-based Biomaterials Market Attractiveness Analysis by Country, 2022-2027

Figure 41: South Asia Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 42: South Asia Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 43: South Asia Collagen and HA-based Biomaterials Market Value Share, By Country, 2022 (E)

Figure 44: South Asia Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2017-2021

Figure 45: South Asia Collagen and HA-based Biomaterials Market Value Forecast (US$ Mn), 2022-2027

Figure 46: South Asia Collagen and HA-based Biomaterials Market Attractiveness Analysis by Type, 2022-2027

Figure 47: South Asia Collagen and HA-based Biomaterials Market Attractiveness Analysis by Application, 2022-2027

Figure 48: South Asia Collagen and HA-based Biomaterials Market Attractiveness Analysis by Country, 2022-2027

Figure 49: East Asia Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 50: East Asia Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 51: East Asia Collagen and HA-based Biomaterials Market Value Share, By Country, 2022 (E)

Figure 52: East Asia Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2017-2021

Figure 53: East Asia Collagen and HA-based Biomaterials Market Value Forecast (US$ Mn), 2022-2027

Figure 54: East Asia Collagen and HA-based Biomaterials Market Attractiveness Analysis by Type, 2022-2027

Figure 55: East Asia Collagen and HA-based Biomaterials Market Attractiveness Analysis by Application, 2022-2027

Figure 56: East Asia Collagen and HA-based Biomaterials Market Attractiveness Analysis by Country, 2022-2027

Figure 57: Oceania Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 58: Oceania Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 59: Oceania Collagen and HA-based Biomaterials Market Value Share, By Country, 2022 (E)

Figure 60: Oceania Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2017-2021

Figure 61: Oceania Collagen and HA-based Biomaterials Market Value Forecast (US$ Mn), 2022-2027

Figure 62: Oceania Collagen and HA-based Biomaterials Market Attractiveness Analysis by Type, 2022-2027

Figure 63: Oceania Collagen and HA-based Biomaterials Market Attractiveness Analysis by Application, 2022-2027

Figure 64: Oceania Collagen and HA-based Biomaterials Market Attractiveness Analysis by Country, 2022-2027

Figure 65: Middle East and Africa Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 66: Middle East and Africa Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 67: Middle East and Africa Collagen and HA-based Biomaterials Market Value Share, By Country, 2022 (E)

Figure 68: Middle East and Africa Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2017-2021

Figure 69: Middle East and Africa Collagen and HA-based Biomaterials Market Value Forecast (US$ Mn), 2022-2027

Figure 70: Middle East and Africa Collagen and HA-based Biomaterials Market Attractiveness Analysis by Type, 2022-2027

Figure 71: Middle East and Africa Collagen and HA-based Biomaterials Market Attractiveness Analysis by Application, 2022-2027

Figure 72: Middle East and Africa Collagen and HA-based Biomaterials Market Attractiveness Analysis by Country, 2022-2027

Figure 73: U. S. Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 74: U. S. Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 75: U. S. Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 76: Canada Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 77: Canada Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 78: Canada Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 79: Mexico Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 80: Mexico Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 81: Mexico Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 82: Brazil Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 83: Brazil Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 84: Brazil Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 85: U. K. Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 86: U. K. Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 87: U. K. Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 88: Germany Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 89: Germany Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 90: Germany Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 91: France Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 92: France Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 93: France Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 94: Italy Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 95: Italy Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 96: Italy Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 97: Spain Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 98: Spain Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 99: Spain Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 100: Russia Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 101: Russia Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 102: Russia Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 103: China Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 104: China Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 105: China Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 106: Japan Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 107: Japan Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 108: Japan Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 109: South Korea Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 110: South Korea Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 111: South Korea Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 112: India Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 113: India Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 114: India Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 115: ASEAN Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 116: ASEAN Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 117: ASEAN Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 118: Australia Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 119: Australia Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 120: Australia Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 121: New Zealand Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 122: New Zealand Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 123: New Zealand Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 124: GCC Countries Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 125: GCC Countries Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 126: GCC Countries Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 127: Turkey Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 128: Turkey Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 129: Turkey Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Figure 130: South Africa Collagen and HA-based Biomaterials Market Value Analysis (US$ Mn), 2022 & 2027

Figure 131: South Africa Collagen and HA-based Biomaterials Market Value Share, By Type, 2022 (E)

Figure 132: South Africa Collagen and HA-based Biomaterials Market Value Share, By Application, 2022 (E)

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

- FAQs -

What is the current value of the collagen and HA-based biomaterials market?

Currently, the global collagen and HA-based biomaterials market is valued at US$ 8 billion.

At what rate is the global collagen and HA-based biomaterials market expected to expand?

Sales of collagen and HA-based biomaterials are expected to increase at 6% CAGR from 2022 to 2027.

What is the projected value for the market for collagen and HA-based biomaterials?

The global collagen and HA-based biomaterials market is predicted to reach US$ 10.8 billion by 2027.

What is the market size for facial aesthetics dermal fillers?

Demand for facial aesthetics dermal fillers is expected to increase at a CAGR of 6.5% and reach US$ 5.5 billion by 2027.

What is the China collagen and HA-based biomaterials market size?

Sales of collagen and HA-based biomaterials in China are expected to surge at 9% CAGR and reach US$ 2 billion by 2027.

Collagen and HA-based Biomaterials Market

Schedule a Call